| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |